Donald Trump faces the prospect of a Republican rebellion when the U.S. House votes on releasing the Epstein files next week ...

David Wickwire, Minh Le, and Craig Sherman are the managing directors for Service Provider Capital's new PNW fund. (Wilson ...

The table below comprises the names of units which are part of the latest syllabus for the 2025 exams. These chapters are intact with minor additions. Discovery of Electron, Proton, and Neutron, ...

The Week 7 NFL schedule features a compelling slate of matchups across the league, highlighted by several key games that could help shape the NFL playoff picture. The Los Angeles Chargers (-1.5, 48.5) ...

Moderately bullish activity in Archer Aviation (ACHR), with shares up 80c, or 7.07%, near $12.04. Options volume relatively light with 122k contracts traded and calls leading puts for a put/call ratio ...

Moderately bullish activity in Iris Energy (IREN), with shares down $5.26 near $62.72. Options volume roughly in line with average with 327k contracts traded and calls leading puts for a put/call ...

HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by ...

Sunday's NFL schedule features four games in the 4 p.m. ET window, including the Indianapolis Colts looking to continue their shocking, dominant start to the season on the road against the Los Angeles ...

Final Fantasy 7 Remake Part 3 co-director Naoki Hamaguchi has assured fans that the team working on the highly anticipated final instalment is "striking a balance" between keeping the story moving and ...

A group of parents and alumni rallied outside the all-boys campus in protest of the Catholic school’s changing tradition.

Action RPGs Square Enix is "actively considering" Final Fantasy 7 Remake Part 3 DLC, Naoki Hamaguchi says, or maybe even another installment entirely: "Things are really up in the air" Final Fantasy ...

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...